Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression

BACKGROUND: Besides providing reassurance about cardiovascular (CV) safety of newer diabetes drugs, cardiovascular outcome trials (CVOTs) have also shown encouraging benefits on some CV endpoints. The contribution of the better glycemic control in the reduction of major cardiovascular events (MACE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Maiorino, Maria Ida, Longo, Miriam, Scappaticcio, Lorenzo, Bellastella, Giuseppe, Chiodini, Paolo, Esposito, Katherine, Giugliano, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522255/
https://www.ncbi.nlm.nih.gov/pubmed/34663316
http://dx.doi.org/10.1186/s12933-021-01401-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522255/
https://www.ncbi.nlm.nih.gov/pubmed/34663316
http://dx.doi.org/10.1186/s12933-021-01401-8

Ejemplares similares